Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Three Review Speeds: Standard, Priority – And Oncology
03 Feb 2021
•
By
Michael McCaughan
FDA’s oncology review team likes to do things its own way – and at its own hyper fast pace.
This three-stick gear shift might look rusty, but the FDA review engine means they are all quite fast.
More from Pink Sheet Perspectives
More from Pink Sheet